| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |